ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
134 hedge funds and large institutions have $1.33B invested in Alder Biopharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 56 increasing their positions, 38 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
4% less funds holding
Funds holding: 140 → 134 (-6)
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
Holders
134
Holding in Top 10
6
Calls
$3.69M
Puts
$3.43M
Top Buyers
| 1 | +$43.4M | |
| 2 | +$25.9M | |
| 3 | +$21.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.1M |
Top Sellers
| 1 | -$23.7M | |
| 2 | -$16.8M | |
| 3 | -$13.4M | |
| 4 |
Morgan Stanley
New York
|
-$7.48M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.5M |